Reaction

Embolic Stroke reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,463 reports · 70 co-occurring drugs

As of the last recalculation, Embolic Stroke appears in 3,463 FAERS reports alongside 70 co-occurring drug terms. The strongest observed disproportionality signal is DABIGATRAN ETEXILATE (PRR 35.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Dabigatran Etexilate	402	35.1	35.2
Dabigatran Etexilate Mesylate	376	34.8	35.0
Rivaroxaban	594	20.5	20.6
Alteplase	36	14.6	14.6
Prasugrel Hydrochloride	24	14.3	14.3
Pitavastatin Calcium	23	13.6	13.6
Cefazolin Sodium	27	13.6	13.6
Asenapine Maleate	17	11.8	11.9
Febuxostat Tablets 40 Mg	19	11.3	11.3
Febuxostat Tablets 80 Mg	19	11.3	11.3
Drospirenone And Ethinyl Estradiol	69	9.6	9.6
Digoxin	108	9.3	9.3
Heparin Sodium	20	8.8	8.8
Cefazolin	13	8.6	8.6
Tranexamic Acid	12	8.1	8.1
Diltiazem Hydrochloride Extended-Release Tablets	15	8.0	8.0
Apixaban	83	7.6	7.6
Febuxostat	21	7.6	7.6
Clopidogrel Bisulfate	114	6.9	6.9
Diltiazem Hydrochloride	38	6.7	6.7
Cyanocobalamin	36	6.6	6.6
Risedronate Sodium	33	6.4	6.4
Warfarin	123	6.0	6.0
Bisoprolol Fumarate	127	5.8	5.8
Tamsulosin Hydrochloride	19	5.6	5.6
Romiplostim	14	5.6	5.6
Tolvaptan	13	5.4	5.4
Clopidogrel	168	5.3	5.3
Ramipril	97	4.8	4.8
Felodipine Extended-Release Tablets	9	4.8	4.8
Felodipine	9	4.8	4.8
Ticagrelor	25	4.7	4.7
Warfarin Sodium	36	4.7	4.7
Dronabinol	6	4.5	4.5
Baricitinib	7	4.4	4.4
Human Insulin	9	4.3	4.3
Amiodarone Hydrochloride	8	4.3	4.3
Spironolactone	97	4.2	4.2
Donepezil Hydrochloride	25	4.1	4.1
Terazosin Hydrochloride	6	4.1	4.1
Anakinra	11	4.0	4.0
Propofol	24	4.0	4.0
Pravastatin Sodium	13	4.0	4.0
Posaconazole Delayed-Release	7	3.8	3.8
Etonogestrel And Ethinyl Estradiol	14	3.8	3.8
Inclisiran	5	3.8	3.8
Raloxifene Hydrochloride	9	3.7	3.7
Metoroprolol Tartrate	40	3.7	3.7
Dronedarone	6	3.5	3.5
Ranibizumab	15	3.4	3.4
Abiraterone	7	3.1	3.1
Axicabtagene Ciloleucel	5	3.0	3.0
Sevoflurane	4	2.9	2.9
Leuprolide Acetate	36	2.8	2.8
Testosterone Cypionate	4	2.7	2.7
Gefitinib	4	2.7	2.7
Romosozumab-Aqqg	6	2.7	2.7
Agalsidase Beta	4	2.6	2.6
Dapagliflozin	13	2.5	2.5
Vortioxetine	7	2.5	2.5
Droxidopa	8	2.2	2.2
Iohexol	3	2.2	2.2
Aflibercept	11	2.1	2.1
Pirfenidone	13	1.9	1.9
Lenvatinib	9	1.7	1.7
Apalutamide	3	1.5	1.5
Enzalutamide	14	1.4	1.4
Abiraterone Acetate	9	1.3	1.3
Osimertinib	6	1.1	1.1
Pomalidomide	18	1.1	1.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.